XML 23 R12.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Financial Instruments
6 Months Ended
Jul. 31, 2024
Fair Value Disclosures [Abstract]  
Financial Instruments
Note 5 – Financial Instruments
The Company classifies its financial instruments within the fair value hierarchy based on the lowest level of input that is significant to the fair value measurement. Three levels of input may be used to measure fair value:
Level 1 – Observable inputs are unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 – Observable inputs are quoted for similar assets and liabilities in active markets or inputs other than quoted prices which are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments.
Level 3 – Unobservable inputs that are supported by little or no market activity and are significant to the fair value of the assets or liabilities. These inputs will be based on the Company’s own assumptions and will require significant management judgement or estimation.
The Company did not have any level 3 investments as of July 31, 2024 and January 31, 2024. The following table summarizes the Company’s cash and available-for-sale marketable securities’ amortized cost, gross unrealized gains, gross unrealized losses, and estimated fair value by significant investment category reported as cash and cash equivalents or short-term investments (in thousands):
Reported as
July 31, 2024Amortized CostGross Unrealized GainsGross
Unrealized
Losses
Estimated Fair ValueCash and Cash EquivalentsShort-Term Investments
Cash:$64,905 $— $— $64,905 $64,905 $— 
Level 1:
Money market funds29,648 — — 29,648 29,648 — 
U.S. Treasuries238,437 265 (14)238,688 — 238,688 
Subtotal268,085 265 (14)268,336 29,648 238,688 
Level 2:
Commercial paper178,964 (25)178,945 47,796 131,149 
Corporate bonds75,981 80 (7)76,054 — 76,054 
U.S. government agencies$13,101 $— $— $13,101 $— $13,101 
Subtotal$268,046 $86 $(32)$268,100 $47,796 $220,304 
Total$601,036 $351 $(46)$601,341 $142,349 $458,992 
Reported as
January 31, 2024Amortized CostGross Unrealized GainsGross
Unrealized
Losses
Estimated Fair ValueCash and Cash EquivalentsShort-Term Investments
Cash:$72,420 $— $— $72,420 $72,420 $— 
Level 1:
Money market funds47,696 — — 47,696 47,696 — 
U.S. Treasuries86,429 70 (13)86,486 — 86,486 
Subtotal134,125 70 (13)134,182 47,696 86,486 
Level 2:
Commercial paper33,019 (3)33,019 9,915 23,104 
Corporate bonds17,883 30 (3)17,910 — 17,910 
U.S. government agencies$21,703 $27 $(10)$21,720 $— $21,720 
Subtotal$72,605 $60 $(16)$72,649 $9,915 $62,734 
Total$279,150 $130 $(29)$279,251 $130,031 $149,220 
The following table summarizes the estimated fair value of the Company’s investments by their remaining contractual maturity dates (in thousands):
July 31, 2024
Due within one year$411,506 
Due between one to two years47,486 
Total$458,992 
For available-for-sale debt securities that have unrealized losses, the Company evaluates whether (i) the Company has the intention to sell any of these investments, (ii) it is not more likely than not that the Company will be required to sell any of these available-for-sale debt securities before recovery of the entire amortized cost basis, and (iii) the decline in the fair value of the investment is due to credit or non-credit related factors. Based on this evaluation, the Company determined that for its short-term investments there were no material credit or non-credit related impairments as of July 31, 2024 and January 31, 2024.